Ivan P. Gergel
2015
In 2015, Ivan P. Gergel earned a total compensation of $1.6M as Senior Vice President and Chief Medical Officer at Nektar Therapeutics, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $279,500 |
|---|---|
| Option Awards | $181,550 |
| Salary | $621,000 |
| Stock Awards | $466,498 |
| Other | $6,657 |
| Total | $1,555,205 |
Gergel received $621K in salary, accounting for 40% of the total pay in 2015.
Gergel also received $279.5K in non-equity incentive plan, $181.6K in option awards, $466.5K in stock awards and $6.7K in other compensation.
Rankings
In 2015, Ivan P. Gergel's compensation ranked 5,812th out of 13,638 executives tracked by ExecPay. In other words, Gergel earned more than 57.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,812 out of 13,638 | 57th |
Division Manufacturing | 2,168 out of 5,187 | 58th |
Major group Chemicals And Allied Products | 781 out of 1,857 | 58th |
Industry group Drugs | 622 out of 1,531 | 59th |
Industry Pharmaceutical Preparations | 487 out of 1,179 | 59th |
Source: SEC filing on April 29, 2016.
Gergel's colleagues
We found five more compensation records of executives who worked with Ivan P. Gergel at Nektar Therapeutics in 2015.
2015
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2015
John Nicholson
Nektar Therapeutics
Chief Financial Officer
2015
Gil Labrucherie
Nektar Therapeutics
General Counsel
2015
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Manufacturing Operations
2015
Stephen Doberstein
Nektar Therapeutics